InsidersTradesSigma
Follow the IDX stock price and the full directors' dealings record of the company, a listed issuer based in Australia. Shares are quoted on AU AU, under the supervision of ASX. Operating in the Health Care sector, IDX has published 4 insider filings. Market capitalisation: €738.7m. The latest transaction was filed on 21 May 2026 (Cease Substantial Holding). Among the most active insiders: Australian Retirement Trust Pty LTD ATF Australian Retirement Trust. All data is openly available.
Analysts rate IDX Strong Buy (bullish), based on 13 analysts. Average price target: A$3.11.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations